These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23118690)

  • 1. Plasma Concentrations Following Application of Whole versus Cut Transdermal Clonidine Patches To Critically Ill Children.
    Zuppa AF; Tejani SM; Cullen EJ; Nadkarni VM
    J Pediatr Pharmacol Ther; 2004 Jan; 9(1):43-8. PubMed ID: 23118690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children.
    Capino AC; Miller JL; Johnson PN
    Pharmacotherapy; 2016 Dec; 36(12):1290-1299. PubMed ID: 27779775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal clonidine for hypertensive patients.
    Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
    Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction.
    Deutsch ES; Nadkarni VM
    Arch Otolaryngol Head Neck Surg; 1996 Nov; 122(11):1234-8. PubMed ID: 8906060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs.
    Egger CM; Duke T; Archer J; Cribb PH
    Vet Surg; 1998; 27(2):159-66. PubMed ID: 9525032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD; Ehrly AM; Kuhl H
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.
    Weber MA; Drayer JI
    Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of transdermally delivered clonidine.
    MacGregor TR; Matzek KM; Keirns JJ; van Wayjen RG; van den Ende A; van Tol RG
    Clin Pharmacol Ther; 1985 Sep; 38(3):278-84. PubMed ID: 4028622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Transition From Dexmedetomidine to Clonidine for the Prevention of Withdrawal in Critically Ill Pediatric Patients.
    Lee MM; Caylor K; Gockenbach N
    J Pediatr Pharmacol Ther; 2020; 25(2):104-110. PubMed ID: 32071584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies.
    Elshoff JP; Braun M; Andreas JO; Middle M; Cawello W
    Clin Ther; 2012 Apr; 34(4):966-78. PubMed ID: 22401642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV; Petty TL; Nett L; Silvers GW; Sachs DP; Rennard SI; Daughton DM; Grimm RH; Heim C
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
    Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses.
    Hov KR; Neerland BE; Andersen AM; Undseth Ø; Wyller VB; MacLullich AMJ; Skovlund E; Qvigstad E; Wyller TB
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):29. PubMed ID: 29884231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.